HIGHLIGHTS
- What: Three individuals were excluded from the present analysis; one individual who opted out of genetic testing (including RNA sequencing); two individuals who seroconverted in the interval between screening and inoculation were excluded from the present analysis, on the basis that they experienced a recent infection that may affect the biomarker expression that is the focus of this study.
- Who: Joshua Rosenheim from the (UNIVERSITY) have published the paper: SARS-CoV-2 human challenge reveals biomarkers that discriminate early and late phases of respiratory viral infections, in the Journal: (JOURNAL) of 21/07/2023
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.